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Introduction
Hypoparathyroidism is a common complication following 
bilateral thyroid surgery. Temporary hypoparathyroidism 
occurs in approximately 10% to 30% of patients, whereas 
permanent hypoparathyroidism rates are much less 
common being reported in 1% to 3% of patients (1). The 
risk of hypoparathyroidism increases with the extent of 
thyroidectomy, completion thyroidectomy, reoperative 
procedures and central neck clearance (1,2). Parathyroid 
identification and preservation is the mainstay of safe 
thyroid surgery. Efforts should be made to identify 
intraoperatively all four parathyroid glands. Use of a 
meticulous surgical technique and dissection close to 
the thyroid gland aiming at preservation of the intact 
blood supply to the parathyroids, and keeping away from 
unnecessary manipulation of parathyroids in due course 
of the dissection are well established factors contributing 
to the reduced prevalence of temporary and permanent 
hypocalcemia (1). However, if the parathyroid glands are 
damaged, autotransplantation should be undertaken to 
preserve their function. Implanted glands have a more 
predictable survival compared to devitalized glands that are 
left in situ (3).
In general, parathyroid transplantation can be considered 
in three distinct modes of application:
(I) Fresh parathyroid tissue autotransplantation 
during thyroidectomy in order to reduce the risk of 
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permanent hypoparathyroidism;
(II) Cryopreserved parathyroid tissue autotransplantation 
in patients with permanent hypocalcemia;
(III) Parathyroid allotransplantation in patients with 
permanent hypoparathyroidism when cryopreserved 
parathyroid tissue is not available for grafting.
This paper is aimed to provide a review of current status 
of various parathyroid transplantation techniques in thyroid 
surgery.
Fresh parathyroid tissue autotransplantation
In 1975, Wells et al. reported on a successful parathyroid 
autotransplantation in a large cohort of patients undergoing 
parathyroidectomy with a transplant success rate of 93% (4). 
This study opened the way for further interest in 
reimplantation as an effective method of preservation of 
parathyroid function not only in parathyroid surgery but also 
in thyroid surgery, and especially in patients undergoing total 
thyroidectomy. Parathyroid autotransplantation soon became 
a widely accepted technique in head and neck surgical 
oncology and endocrine surgery as an effective way to reduce 
the risk of permanent postoperative hypocalcemia (5). 
Selective versus routine parathyroid autotransplantation
Indications for parathyroid autotransplantation during 
thyroid surgery are: an inadvertent removal of parathyroid 
gland, finding parathyroid in the surgical specimen soon 
after excision, no anatomical capacity for preservation of the 
parathyroid in situ, and devascularization of the parathyroid 
gland. In such cases parathyroid should be reimplanted 
into the sternocleidomastoid muscle (6). There are several 
techniques in the surgical armamentarium allowing for 
intraoperative determination of parathyroid viability. The 
most commonly adopted techniques are: observation of 
parathyroid color change, and an incisional test to verify 
vitality by inspection of capsular bleeding (7,8). It was also 
proposed to utilize the intraoperative parathyroid hormone 
assay (IOPTH) during thyroidectomy in monitoring 
of parathyroid function and this method turned out to 
be of added-value for the surgical decision making with 
respect to the selective parathyroid tissue reimplantation 
(9,10). Other concepts, such as routine reimplantation 
of at least one parathyroid gland, aiming at abolishing 
the prevalence of permanent hypoparathyroidism can be 
taken into account, but are associated with a markedly 
higher prevalence of transient hypoparathyroidism (9). 
Paloyan et al. reported on a series of 118 patients in 
whom parathyroid autotransplantation was increasingly 
utilized from one-fourth to the vast majority of patients 
undergoing thyroidectomy over consecutive years of the 
study period (11). In general prevalence of permanent 
hypocalcemia was 1.7%. However, the incidence of 
permanent hypoparathyroidism decreased from 3% in 
the beginning of the study to 0% by the end of the study 
when elective parathyroid autotransplantation was used 
in almost all patients. Moreover, Wilson suggested that 
routine reimplantation of at least one parathyroid gland 
is more reliable than leaving the parathyroid in situ even 
if the vascularization seemed to be unaltered because of a 
higher potential of the autograft to produce an expected 
functional outcome preventing the patient form permanent 
hypoparathyroid state (12). 
Autotransplantation techniques
Parathyroid autografts can be placed heterotopically in 
a brachioradialis muscle or in the sternocleidomastoid 
muscle. However, the latter one is preferred during thyroid 
surgery, as additional incision can be avoided and because 
measurement of parathyroid hormone (PTH) gradient is 
not necessary afterwards (1). Before autotransplantation, 
a frozen section of a small fragment of the parathyroid 
gland should be made, particularly in patients operated for 
thyroid malignancy (13). Different methods of parathyroid 
autotransplantation have been described including the 
techniques of slicing, mincing, and injecting a solution of 
suspended parathyroid tissue in saline into the muscle (14). 
The widely accepted technique for hyperplastic parathyroid 
tissue reimplantation was described by Wells et al. (4). 
Parathyroid tissue should be stored for a while in a chilled 
saline soon after excision. After cooling for 30 min, the 
parathyroid glands become firm and can be easily sliced into 
1-mm pieces or 1 mm × 1 mm × 1 mm cubes. In generally, 
10–20 pieces should be inserted into separate muscle 
pockets of the brachioradialis or sternocleidomastoid 
muscle (Figure 1) (4). This technique allows to minimize 
the chances of graft malfunction. Any intramuscular 
hematoma formation may compromise the graft acceptance. 
Gauger et al. reported that an injection of a parathyroid 
tissue suspension in saline was as effective as sectioning or 
mincing of parathyroid gland for autotransplantation in 
patients undergoing thyroid surgery (15). Most patients 
after parathyroid autotransplantation require temporary 
oral calcium and vitamin D supplementation and close 
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biochemical monitoring of serum calcium for 2–4 weeks 
following surgery. Utilizing such an approach markedly 
decreases the incidence of permanent postsurgical 
hypoparathyroidism (6,9). In the majority of published 
series, proof of successful parathyroid autotransplantation 
during thyroid surgery has been recognized based on the 
maintenance of normocalcaemia without need for life-long 
calcium supplementation after experiencing a short-term 
period of postoperative hypocalcaemia (16,17). However, 
in more recent papers it was also confirmed by PTH serum 
level measurements in peripheral blood (10,15).
IOPTH during thyroidectomy for selective parathyroid 
autotransplantation
An intraoperative assessment of parathyroid function 
was reported to be useful in identification of parathyroid 
glands with a degree of impaired vascularity, the method 
which has a potential to facilitate the decision to perform 
autotransplantation (9). In a randomized controlled 
trial of 340 patients undergoing total thyroidectomy 
Barczyński et al. found that IOPTH offered clinically 
important information during thyroid surgery, allowing 
for correct identification of patients with increased risk 
of postoperative hypocalcemia. Selective IOPTH-based 
parathyroid autotransplantation in patients with serum 
PTH levels below 10 ng/L at 10 to 20 minutes after 
total thyroidectomy abolished the risk of permanent 
hypoparathyroidism, and this concept turned out to be as 
effective as elective parathyroid autotransplantation of at 
least one parathyroid gland without IOPTH monitoring. 
In addit ion,  select ive IOPTH-based parathyroid 
reimplantation markedly reduced prevalence of transient 
postoperative hypocalcemia and the overall doses of calcium 
slats used for supplementation in this study arm were lower 
when compared to elective parathyroid autotransplantation 
without IOPTH monitoring (10).
Cryopreserved parathyroid tissue 
autotransplantation
Direct reimplantation of parathyroid glands that are 
damaged or inadvertently removed minimizes the risk 
of graft non viability and non-functionality. However, 
immediate autotransplantation may not be necessary in 
all patients undergoing thyroidectomy as in most subjects 
who experience hypocalcemia postoperatively this state is 
transient. Hence, cryopreservation of parathyroid tissue, 
the concept that was developed by Wells et al. to cope 
with a problem of permanent hypoparathyroidism, can 
be an alternative (4). This method allows for the storage 
of parathyroid tissue and subsequent autotransplantation 
in a delayed manner after the diagnosis of permanent 
hypothyroidism is confirmed (18). The physician is able 
to determine more accurately if there is any residual 
parathyroid tissue left behind with a potential of regaining 
functioning or whether delayed autotransplantation is 
needed (19). However, parathyroid tissue cryopreservation 
entails the potential risk of transplant failure or malfunction 
which is difficult to predict (3). 
Indications for cryopreservation
The obvious indication for autotransplantation of 
cryopreserved parathyroid tissue is permanent iatrogenic 
postsurgical hypoparathyroidism. The prevalence of this 
adverse sequelae following thyroidectomy in a virgin neck 
is below 1–2% if only the operation is performed by an 
experienced thyroid surgeon (18). The risk of permanent 
hypoparathyroidism is considered to be minimal for a 
thyroidectomy alone but increases with more radical 
extent of surgery. In particular, routine central neck 
dissection for thyroid cancer increases few times the risk of 
permanent hypoparathyroidism (20). Hence, the concept 
of prophylactic central neck dissection for papillary thyroid 
cancer remains controversial. Despite the fact that an 
immediate intraoperative autotransplantation is the method 
of choice during a neck operation for thyroid cancer, the 
Figure 1 Intraoperative autotransplantation of devascularized 
parathyroid gland using a slicing technique and reimplantation 
of small pieces of tissue into separate muscle pockets of the 
sternocleidomastoid muscle during thyroid surgery. 
Thyroid gland
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cryopreservation of parathyroid tissue may be rewarding 
for high-risk patients having more risk for recurrent disease 
which makes them more likely to undergo revision neck 
operations in future. Any redo neck surgery, particularly in 
the central neck, involves an increased risk of permanent 
hypoparathyroidism approaching to 30% in some series, 
that can be potentially preventable by reimplantation of 
cryopreserved parathyroid tissue (3,18). During a redo 
neck operation an identification and in situ preservation 
of the functioning of the remaining parathyroid glands is 
much more difficult as the dissection is undertaken in the 
scar tissues. In addition, parathyroids left in situ during 
primary surgery might have been injured as a result of 
inadequate blood supply preservation. Hence, during a 
revision central neck dissection, any remaining functional 
gland inadvertent removal or injury may lead to permanent 
hypoparathyroidism. In general, it is widely accepted for 
a redo central neck dissections that any parathyroid gland 
encountered should be considered to be the last functional 
parathyroid tissue and should be reimplanted immediately 
soon after unintentional removal. However, few small pieces 
of parathyroid tissue can be secured for cryopreservation and 
possible reimplantation in future if any further neck revisions 
lead to permanent hypoparathyroidism later on (18).
Cryopreservation techniques
The parathyroid tissue obtained during thyroid surgery is 
fragmented into 30 to 40 small pieces of 1 mm × 1 mm × 
1 mm. The pieces should be kept sterile and put into 
the chilled saline. Then the supernatant is decanted and 
usually 8–12 tissue pieces are placed into each vial. Then 
the containers are deposed in the freezing medium. The 
use of a standardized cryopreservation method is crucial 
for preserving graft functionality. The most commonly 
utilized freezing medium is 80% Roswell Park Memorial 
Institute (RPMI) 1640 solution (21). The purpose of the 
freezing procedure is to preserve cellular integrity and 
function by gradually changing the temperature. Hence, 
the tubes should be cooled gradually, prior to transfer for 
a long-term storage. Detailed description of a cooling 
technique is out of the scope of this publication and can 
be found in the published literature (22). However, it is 
important to underline that the most important step for 
this stage of the process is gradual cooling by −1 ℃ per 
minute (22). Once the tubes are cooled, they are put into a 
liquid nitrogen freezer and stored at temperatures between 
−170 and −196 ℃ (22).
Autotransplantation technique
Once the parathyroid tissue pieces are thawed and washed at 
body temperature few times, they are ready for grafting (23). 
The non-dominant forearm of the patient is the best site for 
the parathyroid tissue autotransplantation. Reimplantation 
is usually undertaken under local anesthesia. Having made 
surgical incision on the forearm, using a blunt dissection 
technique, 10–20 individual muscle pockets are created 
in the brachioradialis muscle and into each of them 1–3 
parathyroid graft fragments are reimplanted (23). Caution 
must be exercised not to cause any hematoma within the 
intramuscular pockets, which may worsen the vitality of 
transplants (23).
Functionality assessment and outcomes
Complete independence from calcium and vitamin 
D3 supplementation is  considered the successful 
transplantation (23). In case the patient requires treatment 
with calcium slats, with or without vitamin D, with a 
PTH ratio above 1.5, the transplant is considered to be 
partially functional (22). However, in case the patient is 
hypocalcemic in spite of adequate treatment with calcium 
salts, with or without vitamin D, with a PTH ratio below 
1.5, the transplant is considered to be nonfunctional (22). 
Cryopreserved parathyroid tissue grafts turn out to be 
functional in less than 70% of patients, whereas the fresh 
autografts retain functionality in above 90% of patients (21). 
Cryopreserved parathyroid tissue should be utilized within 
18 months, and preferably as soon as possible, as a longer 
storage reduces markedly the delayed autotransplantation 
functionality rate (18).
Parathyroid allotransplantation
Nowadays, allotransplantation of cultured parathyroid cells 
without immunosuppression is an alternative in selected 
patients to calcium and vitamin D3 supplementation in 
treatment of permanent hypoparathyroidism. However, 
it took many years to establish the protocol of cultured 
parathyroid cells allotransplantation.
From the very beginning it was clear that major 
histocompatibility complex (MHC) class I and II antigens 
are expressed on parathyroid tissue limiting ability of direct 
grafting. In the initial animal studies immunosuppression used 
after parathyroid tissue allotransplantation reduced the risk of 
graft rejection to less than 17% compared to 100% rejection 
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rate in animals left without immunosuppression (24). 
In 1975 Wells et al. published outcomes of parathyroid 
allograft transplanted within family members who had 
previously received a kidney transplant and during a 
30-month follow-up the graft remained functional (4). 
In the subsequent years many such transplantations with 
varying success rate were reported in the literature (3,25). 
However, taking into consideration the side-effects of life-
long immunosuppression this treatment is hardly acceptable 
for a relatively indolent disease as iatrogenic permanent 
hypoparathyroidism. Almost a half of parathyroid tissue 
is composed of non-endocrine and highly immunogenic 
cells. Human leucocyte antigen (HLA) class I antigens 
are poorly expressed on parathyroid cells, and are not 
involved in the induction of the process of host versus graft 
rejection. Hence, successful and long-term functioning 
parathyroid allograft is possible when the transplant is free 
of antigen-presenting cells strongly expressing HLA class II 
antigens. Thus, allotransplantation of cultured parathyroid 
cells, but not parathyroids tissue allows for elimination of 
lymphocytes, macrophages, granulocytes, which represent 
so called “passenger cells” and endothelial cells presenting 
HLA class II antigens, responsible to much extent for 
graft rejection. This innovative method of parathyroid 
cells culture preparation for allotransplantation without 
immunosuppression was developed by Woźniewicz et al. (26). 
First in the World successful cultured parathyroids cells 
allotransplantation in humans without immunosuppression 
for permanent hypoparathyroidism was undertaken 
by Tołłoczko et al. in Warsaw, Poland in 1990 (27). In 
1995 this group reported a series of 18 patients with 
postoperative parathyroid insufficiency (after thyroid 
operations) who were treated with cultured, hormonally 
active, living and ABO the same group type parathyroid 
cells. Explants had been taken from two operated patients 
with secondary hyperparathyroidism. Hormonal activity 
of the transplanted parathyroid cells under the fascia of 
the brachioradialis muscle had been confirmed by clinical, 
biochemical tests and the level of PTH in blood serum 
from the vein of non-grafted arm. Hormonal activity of 
the graft was variable but lasted up to 14 months (27). 
In 2007, Nawrot et al. presented encouraging clinical 
outcomes of parathyroid cells allotransplantation for 
surgical hypoparathyroidism in a series of 85 patients 
and described a modified technique of preparing the 
parathyroid grafts using in vitro breeding (28). The method 
allowed for obtaining a new parathyroid cell population 
with a limited expression of immunogenic antigens. As a 
result of 6 weeks of breeding and freezing, the parathyroid 
cells markedly decreased their normal HLA class I antigen 
presenting cells expression and were free of HLA class II 
positive cells. In this study cells grown using that procedure 
were allotransplanted without immunosuppression. 
Sixty patients underwent one allotransplantation, while 
25 patients had a repeat grafting. The cellular allografts 
remained functional for the mean of 6.35±13.08 months. 
In 64 patients (55.1%), the allografts remained functional 
for more than 2 months (28). This study protocol served 
as a basis for development of a clinical protocol of 
allotransplantation of cultured parathyroid cells which 
had been finalized in 2015 and this procedure is nowadays 
reimbursed in Poland by the National Health Fund. In 
the years 1990–2016 a total number of 316 parathyroid 
allotransplantations and redo allotransplantations were 
performed in Warsaw, Poland (personal communication, 
data not published). Objective improvement considered as 
increase in serum PTH level and normalization of serum 
calcium level allowing for decreased in substitution with 
oral calcium and vitamin D3 was observed in 55.1% of 
patients. In addition, 34.5% grafts remained functioning 
within 1–6 months, 10.2% within 6–12 months, 6.2% 
within 12–24 months, and 1.9% within 24–127 months, 
respectively.  Remarkable improvement in patient 
quality of life was observed in patients with permanent 
hypoparathyroidism who had properly functioning 
graft following allotransplantation, which allowed for 
majority of them to return to normal professional and 
social functioning (personal communication, data not 
published). In case of immediately non-functioning graft 
or function withdrawal there is still an option of redo 
allotransplantation as this method is minimally invasive 
and free of any adverse effects. Hence, in XXI century 
cultured parathyroid cell allotransplantation without 
immunosuppression is an alternative in selected patients 
to substitutive treatment for permanent postoperative 
hypoparathyroidism. However, it must be emphasized 
that it is still not widely available. Further research in this 
area is aimed to develop mechanisms for improvement in 
graft survival. It was hypothesized that the combination of 
cultured parathyroid cells and microencapsulation could 
make parathyroid allotransplantation even a more successful 
procedure in the management of permanent symptomatic 
hypoparathyroidism (25,29). Many animal experiments 
with long-term follow-up have shown that the concept 
of microencapsulation is effective. However, it remains 
unclear if the microcapsules prevent immunization itself 
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or rather by the protective effect of tissue separation from 
the immune response. Nevertheless, it was reported also 
in humans that using such a combined technique allows 
for maintaining the functionality of the graft for at least 
20 months without requirement of endovenous calcium 
supplementation (29).
Conclusions
Parathyroid identification and preservation in situ with 
good vascular supply is the mainstay of safe thyroid 
surgery. However, if the parathyroid glands are damaged, 
autotransplantation should be undertaken to preserve their 
function. Parathyroid transplantation can be considered in 
three distinct modes of application: (I) fresh parathyroid 
tissue autotransplantation during thyroidectomy in order 
to reduce the risk of permanent hypoparathyroidism; 
(II) cryopreserved parathyroid tissue autotransplantation 
in  pa t ient s  wi th  permanent  hypoca lcemia ;  ( I I I ) 
parathyroid allotransplantation in patients with permanent 
hypoparathyroidism when cryopreserved parathyroid tissue 
is not available for grafting. Nowadays, allotransplantation 
of cultured parathyroid cells without immunosuppression 
should be taken into consideration in selected patients as an 
alternative to treatment with calcium and vitamin D3 in the 
management of permanent hypoparathyroidism. 
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